PharmGKB summary: acyclovir/ganciclovir pathway.

IF 1.7 3区医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Pharmacogenetics and genomics Pub Date : 2022-07-01 DOI:10.1097/FPC.0000000000000474

Maud Maillard, Li Gong, Rina Nishii, Jun J Yang, Michelle Whirl-Carrillo, Teri E Klein

引用次数: 2

Abstract

Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee and Departments of Biomedical Data Science and Medicine (BMIR), Stanford University, Stanford, California, USA Correspondence to Teri E. Klein, PhD, Department of Biomedical Data Science, Stanford University, 443 Via Ortega, Room 213, Stanford, CA 94305, USA Tel: +1 650 725 0659; e-mail: feedback@pharmgkb.org

Abstract Image

查看原文本刊更多论文

摘要:阿昔洛韦/更昔洛韦通路。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacogenetics and genomics 医学-生物工程与应用微生物

CiteScore

3.20

自引率

3.80%

发文量

审稿时长

3 months

期刊介绍： Pharmacogenetics and Genomics is devoted to the rapid publication of research papers, brief review articles and short communications on genetic determinants in response to drugs and other chemicals in humans and animals. The Journal brings together papers from the entire spectrum of biomedical research and science, including biochemistry, bioinformatics, clinical pharmacology, clinical pharmacy, epidemiology, genetics, genomics, molecular biology, pharmacology, pharmaceutical sciences, and toxicology. Under a single cover, the Journal provides a forum for all aspects of the genetics and genomics of host response to exogenous chemicals: from the gene to the clinic.